NCT05665985View on ClinicalTrials.gov

Effect Of Moringa Leaf Extract On Disease Activity In Rheumatoid Arthritis Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

July 30, 2020

Study Completion Date

September 30, 2020

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Moringa Oleifera

Intervention with Dry Extract of Moringa Oleifera (trade name is Keloreena Ⓡ , registered number in National Food and Drug Registry: 193332021) The dose given is 1000 mg bi in day for 30 days.

Trial Locations (1)

57145

RS UNS (Universitas Sebelas Maret Hospital), Surakarta

All Listed Sponsors
lead

Universitas Sebelas Maret

OTHER

NCT05665985 - Effect Of Moringa Leaf Extract On Disease Activity In Rheumatoid Arthritis Patients | Biotech Hunter | Biotech Hunter